{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T03:10:17Z","timestamp":1776741017244,"version":"3.51.2"},"reference-count":338,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T00:00:00Z","timestamp":1623715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2016\/21\/B\/NZ6\/02028"],"award-info":[{"award-number":["2016\/21\/B\/NZ6\/02028"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Bacterial secretory systems are essential for virulence in human pathogens. The systems have become a target of alternative antibacterial strategies based on small molecules and antibodies. Strategies to use components of the systems to design prophylactics have been less publicized despite vaccines being the preferred solution to dealing with bacterial infections. In the current review, strategies to design vaccines against selected pathogens are presented and connected to the biology of the system. The examples are given for Y. pestis, S. enterica, B. anthracis, S. flexneri, and other human pathogens, and discussed in terms of effectiveness and long-term protection.<\/jats:p>","DOI":"10.3390\/biom11060892","type":"journal-article","created":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T11:00:33Z","timestamp":1623754833000},"page":"892","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Secretory System Components as Potential Prophylactic Targets for Bacterial Pathogens"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9354-8184","authenticated-orcid":false,"given":"Wieslaw","family":"Swietnicki","sequence":"first","affiliation":[{"name":"Department of Immunology of Infectious Diseases, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, ul. R. Weigla 12, 53-114 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1476-0711-12-22","article-title":"New antibiotics for bad bugs: Where are we?","volume":"12","author":"Bassetti","year":"2013","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"238","DOI":"10.12688\/f1000research.18302.1","article-title":"Reinventing the antimicrobial pipeline in response to the global crisis of antimicrobial-resistant infections","volume":"8","author":"Singer","year":"2019","journal-title":"F1000research"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1038\/d41586-020-02884-3","article-title":"Why big pharma has abandoned antibiotics","volume":"586","author":"Plackett","year":"2020","journal-title":"Nature"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.mib.2003.08.003","article-title":"Why is big Pharma getting out of antibacterial drug discovery?","volume":"6","author":"Projan","year":"2003","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.copbio.2016.04.006","article-title":"Evolving medicinal chemistry strategies in antibiotic discovery","volume":"42","author":"Pawlowski","year":"2016","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1586\/eri.11.107","article-title":"Will new antimicrobials overcome resistance among Gram-negatives?","volume":"9","author":"Bassetti","year":"2011","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.bcp.2005.11.012","article-title":"Understanding the longevity of the beta-lactam antibiotics and of antibiotic\/beta-lactamase inhibitor combinations","volume":"71","author":"Buynak","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/14740338.2021.1857362","article-title":"Safety considerations of current drug treatment strategies for nosocomial pneumonia","volume":"20","author":"Ceccato","year":"2021","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"100423","DOI":"10.1016\/j.tcr.2021.100423","article-title":"\u201cCiprofloxacin-induced\u201d bilateral quadriceps tendon rupture: A case report and conclusions of the recent literature","volume":"32","author":"Suter","year":"2021","journal-title":"Trauma Case Rep."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"(2018). New money flows to CARB-X for antimicrobials. Nat. Biotechnol., 36, 560.","DOI":"10.1038\/nbt0718-560"},{"key":"ref_11","first-page":"277","article-title":"The antibiotic resistance crisis: Part 1: Causes and threats","volume":"40","author":"Ventola","year":"2015","journal-title":"Pharm. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3389\/fpubh.2014.00145","article-title":"The antimicrobial resistance crisis: Causes, consequences, and management","volume":"2","author":"Michael","year":"2014","journal-title":"Front. Public Health"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Romandini, A., Pani, A., Schenardi, P.A., Pattarino, G.A.C., De Giacomo, C., and Scaglione, F. (2021). Antibiotic Resistance in Pediatric Infections: Global Emerging Threats, Predicting the Near Future. Antibiotics, 10.","DOI":"10.3390\/antibiotics10040393"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s40259-021-00480-z","article-title":"Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future","volume":"35","year":"2021","journal-title":"BioDrugs"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.mib.2020.08.001","article-title":"Bacterial signaling as an antimicrobial target","volume":"57","author":"Ellermann","year":"2020","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2796.2008.01941.x","article-title":"Virulence blockers as alternatives to antibiotics: Type III secretion inhibitors against Gram-negative bacteria","volume":"264","author":"Keyser","year":"2008","journal-title":"J. Intern. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrd.2016.155","article-title":"Accelerating global innovation to address antibacterial resistance: Introducing CARB-X","volume":"15","author":"Outterson","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41579-019-0288-0","article-title":"The global preclinical antibacterial pipeline","volume":"18","author":"Theuretzbacher","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3389\/fimmu.2020.01048","article-title":"Vaccines against Antimicrobial Resistance","volume":"11","author":"Rosini","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/biostatistics\/kxx069","article-title":"Estimation of clinical trial success rates and related parameters","volume":"20","author":"Wong","year":"2019","journal-title":"Biostatistics"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ijmm.2017.09.013","article-title":"Staphylococcus aureus strategies to evade the host acquired immune response","volume":"308","author":"Goldmann","year":"2018","journal-title":"Int. J. Med. Microbiol. IJMM"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrmicro3308","article-title":"Models matter: The search for an effective Staphylococcus aureus vaccine","volume":"12","author":"Schlievert","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Hotinger, J.A., Pendergrass, H.A., and May, A.E. (2021). Molecular Targets and Strategies for Inhibition of the Bacterial Type III Secretion System (T3SS); Inhibitors Directly Binding to T3SS Components. Biomolecules, 11.","DOI":"10.3390\/biom11020316"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"632706","DOI":"10.3389\/fmicb.2020.632706","article-title":"Antivirulence Strategies for the Treatment of Staphylococcus aureus Infections: A Mini Review","volume":"11","author":"Ford","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1574-6968.2012.02583.x","article-title":"A Yersinia pestis YscN ATPase mutant functions as a live attenuated vaccine against bubonic plague in mice","volume":"332","author":"Bozue","year":"2012","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40168-020-00993-9","article-title":"PathoFact: A pipeline for the prediction of virulence factors and antimicrobial resistance genes in metagenomic data","volume":"9","author":"Lopes","year":"2021","journal-title":"Microbiome"},{"key":"ref_27","unstructured":"Siles, M.L., Lugo, A.C., and McConnell, M.J. (2020). Vaccines for multidrug resistant Gram negative bacteria: Lessons from the past for guiding future success. FEMS Microbiol. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Repizo, G.D., Gagne, S., Foucault-Grunenwald, M.L., Borges, V., Charpentier, X., Limansky, A.S., Gomes, J.P., Viale, A.M., and Salcedo, S.P. (2015). Differential Role of the T6SS in Acinetobacter baumannii Virulence. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0138265"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Wang, J., Zhou, Z., He, F., Ruan, Z., Jiang, Y., Hua, X., and Yu, Y. (2018). The role of the type VI secretion system vgrG gene in the virulence and antimicrobial resistance of Acinetobacter baumannii ATCC 19606. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0192288"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Li, X., Pan, C., Liu, Z., Sun, P., Hua, X., Feng, E., Yu, Y., Wu, J., Zhu, L., and Wang, H. (2021). Safety and immunogenicity of a new glycoengineered vaccine against Acinetobacter baumannii in mice. Microb. Biotechnol.","DOI":"10.1111\/1751-7915.13770"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Gellings, P.S., Wilkins, A.A., and Morici, L.A. (2020). Recent Advances in the Pursuit of an Effective Acinetobacter baumannii Vaccine. Pathogens, 9.","DOI":"10.3390\/pathogens9121066"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Hassan, A., Naz, A., Obaid, A., Paracha, R.Z., Naz, K., Awan, F.M., Muhmmad, S.A., Janjua, H.A., Ahmad, J., and Ali, A. (2016). Pangenome and immuno-proteomics analysis of Acinetobacter baumannii strains revealed the core peptide vaccine targets. BMC Genom., 17.","DOI":"10.1186\/s12864-016-2951-4"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1046\/j.1365-2672.1999.00883.x","article-title":"Sequence, assembly and analysis of pX01 and pX02","volume":"87","author":"Okinaka","year":"1999","journal-title":"J. Appl. Microbiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1128\/jb.171.2.722-730.1989","article-title":"Molecular characterization and protein analysis of the cap region, which is essential for encapsulation in Bacillus anthracis","volume":"171","author":"Makino","year":"1989","journal-title":"J. Bacteriol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1073\/pnas.79.10.3162","article-title":"Anthrax toxin edema factor: A bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells","volume":"79","author":"Leppla","year":"1982","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_36","first-page":"189","article-title":"Bacillus anthracis calmodulin-dependent adenylate cyclase: Chemical and enzymatic properties and interactions with eucaryotic cells","volume":"17","author":"Leppla","year":"1984","journal-title":"Adv. Cycl. Nucleotide Protein Phosphorylation Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1365-2958.1994.tb00500.x","article-title":"Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity","volume":"13","author":"Klimpel","year":"1994","journal-title":"Mol. Microbiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1080\/21645515.2020.1799668","article-title":"Characterization of the UK anthrax vaccine and human immunogenicity","volume":"17","author":"Modi","year":"2021","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4049\/jimmunol.1501903","article-title":"A CpG-Ficoll Nanoparticle Adjuvant for Anthrax Protective Antigen Enhances Immunogenicity and Provides Single-Immunization Protection against Inhaled Anthrax in Monkeys","volume":"196","author":"Kachura","year":"2016","journal-title":"J. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Oh, Y., Kim, J.A., Kim, C.-H., Choi, S.-K., and Pan, J.-G. (2020). Bacillus subtilis spore vaccines displaying protective antigen induce functional antibodies and protective potency. BMC Vet. Res., 16.","DOI":"10.1186\/s12917-020-02468-3"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.1128\/IAI.66.12.5921-5929.1998","article-title":"Filamentous hemagglutinin of Bordetella bronchiseptica is required for efficient establishment of tracheal colonization","volume":"66","author":"Cotter","year":"1998","journal-title":"Infect. Immun."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1073\/pnas.86.8.2637","article-title":"Filamentous hemagglutinin of Bordetella pertussis: Nucleotide sequence and crucial role in adherence","volume":"86","author":"Relman","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/iai.52.3.695-701.1986","article-title":"Filamentous hemagglutinin has a major role in mediating adherence of Bordetella pertussis to human WiDr cells","volume":"52","author":"Urisu","year":"1986","journal-title":"Infect. Immun."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/mmi.14318","article-title":"Regulated, sequential processing by multiple proteases is required for proper maturation and release of Bordetella filamentous hemagglutinin","volume":"112","author":"Nash","year":"2019","journal-title":"Mol. Microbiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.tvjl.2015.02.006","article-title":"How well do vaccines for Bordetella bronchiseptica work in dogs? A critical review of the literature 1977\u20132014","volume":"204","author":"Ellis","year":"2015","journal-title":"Vet. J."},{"key":"ref_46","first-page":"297","article-title":"Immunologic study and optimization of Salmonella delivery strains expressing adhesin and toxin antigens for protection against progressive atrophic rhinitis in a murine model","volume":"78","author":"Hur","year":"2014","journal-title":"Can. J. Vet. Res. Rev. Can. Rech. Vet."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1128\/IAI.01495-07","article-title":"Subcutaneous vaccination with attenuated Salmonella enterica serovar Choleraesuis C500 expressing recombinant filamentous hemagglutinin and pertactin antigens protects mice against fatal infections with both S. enterica serovar Choleraesuis and Bordetella bronchiseptica","volume":"76","author":"Zhao","year":"2008","journal-title":"Infect. Immun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3389\/fcimb.2020.00466","article-title":"Bordetella Type III Secretion Injectosome and Effector Proteins","volume":"10","author":"Kamanova","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/infdis\/jit639","article-title":"Pertussis pathogenesis\u2014What we know and what we don\u2019t know","volume":"209","author":"Hewlett","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1128\/IAI.00836-07","article-title":"Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses","volume":"76","author":"Fennelly","year":"2008","journal-title":"Infect. Immun."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/jpids\/piz005","article-title":"The 112-Year Odyssey of Pertussis and Pertussis Vaccines-Mistakes Made and Implications for the Future","volume":"8","author":"Cherry","year":"2019","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Ross, P.J., Sutton, C.E., Higgins, S., Allen, A.C., Walsh, K., Misiak, A., Lavelle, E.C., McLoughlin, R.M., and Mills, K.H.G. (2013). Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: Towards the rational design of an improved acellular pertussis vaccine. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003264"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1172\/JCI135020","article-title":"Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans","volume":"130","author":"Lin","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/j.vaccine.2005.01.120","article-title":"Attenuated Bordetella pertussis: New live vaccines for intranasal immunisation","volume":"24","author":"Mielcarek","year":"2006","journal-title":"Vaccine"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2217\/fmb-2017-0064","article-title":"Physiopathological roles of spontaneously released outer membrane vesicles of Bordetella pertussis","volume":"12","author":"Gasperini","year":"2017","journal-title":"Future Microbiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.vaccine.2013.12.048","article-title":"Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypes","volume":"32","author":"Gaillard","year":"2014","journal-title":"Vaccine"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1080\/21691401.2019.1629948","article-title":"Bordetella pertussis antigens encapsulated into N-trimethyl chitosan nanoparticulate systems as a novel intranasal pertussis vaccine","volume":"47","author":"Najminejad","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"100255","DOI":"10.1016\/j.onehlt.2021.100255","article-title":"Molecular characterization and antimicrobial susceptibility testing of clinical and non-clinical Brucella melitensis and Brucella abortus isolates from Egypt","volume":"13","author":"Wareth","year":"2021","journal-title":"One Health"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Crasta, O.R., Folkerts, O., Fei, Z., Mane, S.P., Evans, C., Martino-Catt, S., Bricker, B., Yu, G., Du, L., and Sobral, B.W. (2008). Genome sequence of Brucella abortus vaccine strain S19 compared to virulent strains yields candidate virulence genes. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0002193"},{"key":"ref_60","first-page":"62","article-title":"Brucella abortus S19 rfbD mutant is highly attenuated, DIVA enable and confers protection against virulent challenge in mice","volume":"63","author":"Lalsiamthara","year":"2020","journal-title":"Biol. J. Int. Assoc. Biol. Stand."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0007-1935(85)90046-6","article-title":"The effect of reduced-dose Brucella abortus strain 19 vaccination in accredited dairy herds","volume":"141","author":"Beckett","year":"1985","journal-title":"Br. Vet. J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1128\/CVI.00653-14","article-title":"Immunization with Brucella VirB proteins reduces organ colonization in mice through a Th1-type immune response and elicits a similar immune response in dogs","volume":"22","author":"Pollak","year":"2015","journal-title":"Clin. Vaccine Immunol. CVI"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Viadas, C., Rodriguez, M.C., Sangari, F.J., Gorvel, J.-P., Garcia-Lobo, J.M., and Lopez-Goni, I. (2010). Transcriptome analysis of the Brucella abortus BvrR\/BvrS two-component regulatory system. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0010216"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.micpath.2017.01.043","article-title":"Brucella abortus 2308DeltaNodVDeltaNodW double-mutant is highly attenuated and confers protection against wild-type challenge in BALB\/c mice","volume":"106","author":"Li","year":"2017","journal-title":"Microb. Pathog."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0167-5877(96)01110-5","article-title":"A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats","volume":"31","author":"Blasco","year":"1997","journal-title":"Prev. Vet. Med."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Ranjbar, M. (2015). Updates on Brucellosis: Treatment of Brucellosis, INTECH Publishing.","DOI":"10.5772\/61093"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.micinf.2014.06.013","article-title":"Evaluation of a Brucella melitensis mutant deficient in O-polysaccharide export system ATP-binding protein as a rough vaccine candidate","volume":"16","author":"Wang","year":"2014","journal-title":"Microbes Infect."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","article-title":"Global causes of blindness and distance vision impairment 1990\u20132020: A systematic review and meta-analysis","volume":"5","author":"Flaxman","year":"2017","journal-title":"Lancet Glob. Health"},{"key":"ref_69","first-page":"4","article-title":"Genital Chlamydia trachomatis infections","volume":"15","author":"Bebear","year":"2009","journal-title":"Clin. Microbiol. Infect Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1586\/14787210.2014.901169","article-title":"Lymphogranuloma venereum among men who have sex with men. An epidemiological and clinical review","volume":"12","year":"2014","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1016\/j.vaccine.2009.02.095","article-title":"A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice","volume":"27","author":"Wang","year":"2009","journal-title":"Vaccine"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1016\/j.vaccine.2016.06.046","article-title":"Immunization with chlamydial type III secretion antigens reduces vaginal shedding and prevents fallopian tube pathology following live C. muridarum challenge","volume":"34","author":"Bulir","year":"2016","journal-title":"Vaccine"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1016\/j.vaccine.2021.03.043","article-title":"Chlamydia trachomatis: Cell biology, immunology and vaccination","volume":"39","author":"Murray","year":"2021","journal-title":"Vaccine"},{"key":"ref_74","first-page":"e00543-16","article-title":"Update on Chlamydia trachomatis Vaccinology","volume":"24","author":"Zhong","year":"2017","journal-title":"Clin. Vaccine Immunol. CVI"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1016\/j.vaccine.2009.12.020","article-title":"Identification of immunodominant antigens of Chlamydia trachomatis using proteome microarrays","volume":"28","author":"Molina","year":"2010","journal-title":"Vaccine"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1473-3099(19)30279-8","article-title":"Safety and immunogenicity of the Chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: A first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial","volume":"19","author":"Abraham","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1590\/S0074-02762004000600001","article-title":"Diarrheagenic Escherichia coli categories among the traditional enteropathogenic E. coli O serogroups\u2014A review","volume":"99","author":"Campos","year":"2004","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1128\/iai.62.8.3282-3288.1994","article-title":"Escherichia coli serogroup O111 includes several clones of diarrheagenic strains with different virulence properties","volume":"62","author":"Campos","year":"1994","journal-title":"Infect. Immun."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"EHEC-0007-2013","DOI":"10.1128\/microbiolspec.EHEC-0007-2013","article-title":"The Locus of Enterocyte Effacement and Associated Virulence Factors of Enterohemorrhagic Escherichia coli","volume":"2","author":"Stevens","year":"2014","journal-title":"Microbiol. Spectr."},{"key":"ref_80","first-page":"11","article-title":"Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12","volume":"8","author":"Hayashi","year":"2001","journal-title":"DNA Res. Int. J. Rapid Publ. Rep. Genes Genomes"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/35054089","article-title":"Genome sequence of enterohaemorrhagic Escherichia coli O157:H7","volume":"409","author":"Perna","year":"2001","journal-title":"Nature"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/nrmicro2265","article-title":"Molecular mechanisms of Escherichia coli pathogenicity","volume":"8","author":"Croxen","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_83","first-page":"213","article-title":"Vaccines Against Escherichia coli","volume":"416","author":"Nesta","year":"2018","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Marley, K.B., Kuehn, L.A., Keele, J.W., Wileman, B.W., and Gonda, M.G. (2018). Genetic variation in humoral response to an Escherichia coli O157:H7 vaccine in beef cattle. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0197347"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.vaccine.2009.10.076","article-title":"Immunization of cattle with a combination of purified intimin-531, EspA and Tir significantly reduces shedding of Escherichia coli O157:H7 following oral challenge","volume":"28","author":"McNeilly","year":"2010","journal-title":"Vaccine"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1863-2378.2012.01523.x","article-title":"Assessing the existing information on the efficacy of bovine vaccination against Escherichia coli O157:H7\u2014A systematic review and meta-analysis","volume":"60","author":"Varela","year":"2013","journal-title":"Zoonoses Public Health"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.4161\/21645515.2014.972145","article-title":"A universal polysaccharide conjugated vaccine against O111 E. coli","volume":"10","author":"Andrade","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.vetmic.2017.10.006","article-title":"Secretion of the Shiga toxin B subunit (Stx1B) via an autotransporter protein optimizes the protective immune response to the antigen expressed in an attenuated E. coli (rEPEC E22Deltaler) vaccine strain","volume":"211","author":"Byrd","year":"2017","journal-title":"Vet. Microbiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1016\/j.vaccine.2005.07.019","article-title":"Towards a vaccine for attaching\/effacing Escherichia coli: A LEE encoded regulator (ler) mutant of rabbit enteropathogenic Escherichia coli is attenuated, immunogenic, and protects rabbits from lethal challenge with the wild-type virulent strain","volume":"24","author":"Zhu","year":"2006","journal-title":"Vaccine"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fcimb.2018.00154","article-title":"Live Attenuated Tularemia Vaccines for Protection against Respiratory Challenge with Virulent F. tularensis subsp. tularensis","volume":"8","author":"Jia","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/jb.61.5.557-569.1951","article-title":"Studies on the variation of Bacterium tularense","volume":"61","author":"Eigelsbach","year":"1951","journal-title":"J. Bacteriol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1128\/IAI.00192-10","article-title":"A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge","volume":"78","author":"Jia","year":"2010","journal-title":"Infect. Immun."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1016\/j.vaccine.2016.08.041","article-title":"Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge","volume":"34","author":"Jia","year":"2016","journal-title":"Vaccine"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0882-4010(92)90025-J","article-title":"The 17 kDa lipoprotein and encoding gene of Francisella tularensis LVS are conserved in strains of Francisella tularensis","volume":"13","author":"Sjostedt","year":"1992","journal-title":"Microb. Pathog."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0264-410X(95)93311-V","article-title":"Adjuvanticity of ISCOMs incorporating a T cell-reactive lipoprotein of the facultative intracellular pathogen Francisella tularensis","volume":"13","author":"Golovliov","year":"1995","journal-title":"Vaccine"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1016\/S0264-410X(01)00189-X","article-title":"Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis","volume":"19","author":"Fulop","year":"2001","journal-title":"Vaccine"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1016\/S0264-410X(02)00345-6","article-title":"Mice vaccinated with the O-antigen of Francisella tularensis LVS lipopolysaccharide conjugated to bovine serum albumin develop varying degrees of protective immunity against systemic or aerosol challenge with virulent type A and type B strains of the pathogen","volume":"20","author":"Conlan","year":"2002","journal-title":"Vaccine"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1099\/00207713-44-1-38","article-title":"Analysis of 16S ribosomal DNA sequences of Francisella strains and utilization for determination of the phylogeny of the genus and for identification of strains by PCR","volume":"44","author":"Forsman","year":"1994","journal-title":"Int. J. Syst. Bacteriol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"5554","DOI":"10.1016\/j.vaccine.2009.07.034","article-title":"Vaccination with a defined Francisella tularensis subsp. novicida pathogenicity island mutant (DeltaiglB) induces protective immunity against homotypic and heterotypic challenge","volume":"27","author":"Cong","year":"2009","journal-title":"Vaccine"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Signarovitz, A.L., Ray, H.J., Yu, J.J., Guentzel, M.N., Chambers, J.P., Klose, K.E., and Arulanandam, B.P. (2012). Mucosal immunization with live attenuated Francisella novicida U112DeltaiglB protects against pulmonary F. tularensis SCHU S4 in the Fischer 344 rat model. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0047639"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1016\/j.vaccine.2014.07.038","article-title":"Enhancement of vaccine efficacy by expression of a TLR5 ligand in the defined live attenuated Francisella tularensis subsp. novicida strain U112DeltaiglB::fljB","volume":"32","author":"Cunningham","year":"2014","journal-title":"Vaccine"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Chu, P., Cunningham, A.L., Yu, J.J., Nguyen, J.Q., Barker, J.R., Lyons, C.R., Wilder, J., Valderas, M., Sherwood, R.L., and Arulanandam, B.P. (2014). Live attenuated Francisella novicida vaccine protects against Francisella tularensis pulmonary challenge in rats and non-human primates. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004439"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1128\/IAI.00351-07","article-title":"Identification of an orphan response regulator required for the virulence of Francisella spp. and transcription of pathogenicity island genes","volume":"75","author":"Mohapatra","year":"2007","journal-title":"Infect. Immun."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1038\/s41598-018-24581-y","article-title":"Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia","volume":"8","author":"Jia","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1128\/CVI.00738-13","article-title":"Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strain","volume":"21","author":"Richard","year":"2014","journal-title":"Clin. Vaccine Immunol. CVI"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1053\/j.gastro.2009.01.073","article-title":"Helicobacter pylori in health and disease","volume":"136","author":"Cover","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1073\/pnas.0506655103","article-title":"Molecular analysis of the bacterial microbiota in the human stomach","volume":"103","author":"Bik","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Andersson, A.F., Lindberg, M., Jakobsson, H., Backhed, F., Nyren, P., and Engstrand, L. (2008). Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0002836"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"The EUROGAST Study Group (1993). An international association between Helicobacter pylori infection and gastric cancer. Lancet, 341, 1359\u20131362.","DOI":"10.1016\/0140-6736(93)90938-D"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1523-5378.2005.00305.x","article-title":"Role of Helicobacter pylori in gastric carcinogenesis: The origin of gastric cancers and heterotopic proliferative glands in Mongolian gerbils","volume":"10","author":"Tatematsu","year":"2005","journal-title":"Helicobacter"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"6089","DOI":"10.1093\/nar\/gkq378","article-title":"Strain-specific genes of Helicobacter pylori: Genome evolution driven by a novel type IV secretion system and genomic island transfer","volume":"38","author":"Fischer","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1038\/s41598-021-83862-1","article-title":"Helicobacter pylori type 4 secretion systems as gastroduodenal disease markers","volume":"11","author":"Phuc","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/j.1462-5822.2008.01156.x","article-title":"Role of type IV secretion in Helicobacter pylori pathogenesis","volume":"10","author":"Backert","year":"2008","journal-title":"Cell. Microbiol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nature06187","article-title":"Helicobacter exploits integrin for type IV secretion and kinase activation","volume":"449","author":"Kwok","year":"2007","journal-title":"Nature"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nrmicro1095","article-title":"Helicobacter pylori VacA, a paradigm for toxin multifunctionality","volume":"3","author":"Cover","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1128\/IAI.73.3.1584-1589.2005","article-title":"Rapid loss of motility of Helicobacter pylori in the gastric lumen in vivo","volume":"73","author":"Schreiber","year":"2005","journal-title":"Infect. Immun."},{"key":"ref_117","first-page":"411","article-title":"Oral immunization of mice with vaccine of attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit","volume":"18","author":"Yang","year":"2005","journal-title":"Biomed. Environ. Sci. BES"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/2049-632X.12173","article-title":"Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice","volume":"72","author":"Li","year":"2014","journal-title":"Pathog. Dis."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0264-410X(97)00153-9","article-title":"Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant","volume":"16","author":"Marchetti","year":"1998","journal-title":"Vaccine"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1128\/iai.65.12.4996-5002.1997","article-title":"Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection","volume":"65","author":"Ghiara","year":"1997","journal-title":"Infect. Immun."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1016\/S0264-410X(02)00104-4","article-title":"Immune responses in mice to intranasal and intracutaneous administration of a DNA vaccine encoding Helicobacter pylori-catalase","volume":"20","author":"Miyashita","year":"2002","journal-title":"Vaccine"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12951-020-00618-1","article-title":"Effect of the cagW-based gene vaccine on the immunologic properties of BALB\/c mouse: An efficient candidate for Helicobacter pylori DNA vaccine","volume":"18","author":"Chehelgerdi","year":"2020","journal-title":"J. Nanobiotechnol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"9495","DOI":"10.1007\/s00253-015-6705-z","article-title":"A novel chimeric flagellum fused with the multi-epitope vaccine CTB-UE prevents Helicobacter pylori-induced gastric cancer in a BALB\/c mouse model","volume":"99","author":"Song","year":"2015","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejpb.2016.11.007","article-title":"Oral Helicobacter pylori vaccine-encapsulated acid-resistant HP55\/PLGA nanoparticles promote immune protection","volume":"111","author":"Tan","year":"2017","journal-title":"Eur. J. Pharm. Biopharm. Off. J. Arb. Pharm. Verfahr. V"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1128\/iai.51.1.94-101.1986","article-title":"Outer membrane proteins from Legionella pneumophila serogroups and other Legionella species","volume":"51","author":"Hindahl","year":"1986","journal-title":"Infect. Immun."},{"key":"ref_126","first-page":"91","article-title":"Legionella pneumophila: Extraction of the main protein from the outer membrane (p29)","volume":"54","author":"Sosa","year":"2002","journal-title":"Rev. Cuba. Med. Trop."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1128\/IAI.66.4.1768-1775.1998","article-title":"Expression of multiple pili by Legionella pneumophila: Identification and characterization of a type IV pilin gene and its role in adherence to mammalian and protozoan cells","volume":"66","author":"Stone","year":"1998","journal-title":"Infect. Immun."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.diagmicrobio.2012.02.013","article-title":"Protective immunity against Legionnaires\u2019 disease in an A\/J mouse model using a DNA vaccine composed of an outer membrane protein (29 kDa) and the pilE fusion protein","volume":"73","author":"Xu","year":"2012","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Chen, Y., Yang, Z., Dong, Y., and Chen, Y. (2020). Recombinant PAL\/PilE\/FlaA DNA vaccine provides protective immunity against Legionella pneumophila in BALB\/c mice. BMC Biotechnol., 20.","DOI":"10.1186\/s12896-020-00620-3"},{"key":"ref_130","first-page":"1481","article-title":"Preventive Vaccination against Tuberculosis with BCG","volume":"24","author":"Calmette","year":"1931","journal-title":"Proc. R. Soc. Med."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Zwerling, A., Behr, M.A., Verma, A., Brewer, T.F., Menzies, D., and Pai, M. (2011). The BCG World Atlas: A database of global BCG vaccination policies and practices. PLoS Med., 8.","DOI":"10.1371\/journal.pmed.1001012"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1128\/jb.178.5.1274-1282.1996","article-title":"Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis","volume":"178","author":"Mahairas","year":"1996","journal-title":"J. Bacteriol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nrmicro.2016.131","article-title":"ESX secretion systems: Mycobacterial evolution to counter host immunity","volume":"14","author":"Groschel","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1128\/CDLI.7.2.155-160.2000","article-title":"Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10","volume":"7","author":"Ravn","year":"2000","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"12420","DOI":"10.1073\/pnas.1635213100","article-title":"The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue","volume":"100","author":"Hsu","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1086\/345862","article-title":"Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guerin attenuation","volume":"187","author":"Lewis","year":"2003","journal-title":"J. Infect. Dis."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"46666","DOI":"10.1038\/srep46666","article-title":"An attenuated Mycobacterium tuberculosis clinical strain with a defect in ESX-1 secretion induces minimal host immune responses and pathology","volume":"7","author":"Clemmensen","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"6028","DOI":"10.1128\/JB.00469-07","article-title":"ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity","volume":"189","author":"Fretz","year":"2007","journal-title":"J. Bacteriol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"e12726","DOI":"10.1111\/cmi.12726","article-title":"ESX-1 and phthiocerol dimycocerosates of Mycobacterium tuberculosis act in concert to cause phagosomal rupture and host cell apoptosis","volume":"19","author":"Augenstreich","year":"2017","journal-title":"Cell. Microbiol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1073\/pnas.1620133114","article-title":"Mycobacterial ESX-1 secretion system mediates host cell lysis through bacterium contact-dependent gross membrane disruptions","volume":"114","author":"Conrad","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1128\/mr.56.4.648-661.1992","article-title":"The antigen 85 complex: A major secretion product of Mycobacterium tuberculosis","volume":"56","author":"Wiker","year":"1992","journal-title":"Microbiol. Rev."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1128\/IAI.68.7.3933-3940.2000","article-title":"Identification and HLA restriction of naturally derived Th1-cell epitopes from the secreted Mycobacterium tuberculosis antigen 85B recognized by antigen-specific human CD4(+) T-cell lines","volume":"68","author":"Mustafa","year":"2000","journal-title":"Infect. Immun."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1128\/IAI.69.5.2773-2778.2001","article-title":"Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6","volume":"69","author":"Andersen","year":"2001","journal-title":"Infect. Immun."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1073\/pnas.92.5.1530","article-title":"Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis","volume":"92","author":"Horwitz","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1128\/IAI.66.6.2951-2959.1998","article-title":"Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis","volume":"66","author":"Baldwin","year":"1998","journal-title":"Infect. Immun."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/IAI.68.2.791-795.2000","article-title":"ESAT-6 subunit vaccination against Mycobacterium tuberculosis","volume":"68","author":"Brandt","year":"2000","journal-title":"Infect. Immun."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.1128\/IAI.72.10.6148-6150.2004","article-title":"Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model","volume":"72","author":"Olsen","year":"2004","journal-title":"Infect. Immun."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1016\/j.vaccine.2016.10.065","article-title":"Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B","volume":"34","author":"Dai","year":"2016","journal-title":"Vaccine"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm.2285","article-title":"A multistage tuberculosis vaccine that confers efficient protection before and after exposure","volume":"17","author":"Aagaard","year":"2011","journal-title":"Nat. Med."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1128\/iai.58.4.1120-1123.1990","article-title":"Construction of a urease-negative mutant of Proteus mirabilis: Analysis of virulence in a mouse model of ascending urinary tract infection","volume":"58","author":"Jones","year":"1990","journal-title":"Infect. Immun."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1128\/jcm.25.11.2216-2217.1987","article-title":"Urease-positive bacteriuria and obstruction of long-term urinary catheters","volume":"25","author":"Mobley","year":"1987","journal-title":"J. Clin. Microbiol."},{"key":"ref_152","first-page":"346","article-title":"Urease. The primary cause of infection-induced urinary stones","volume":"13","author":"Griffith","year":"1976","journal-title":"Investig. Urol."},{"key":"ref_153","first-page":"278","article-title":"Infection (urease) stones","volume":"13","author":"Griffith","year":"1987","journal-title":"Miner. Electrolyte Metab."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0022-5347(17)50311-0","article-title":"Bacteriology of branched renal calculi and accompanying urinary tract infection","volume":"131","author":"Fowler","year":"1984","journal-title":"J. Urol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0022-5347(17)41002-0","article-title":"Infection stones","volume":"141","author":"Lerner","year":"1989","journal-title":"J. Urol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1139\/m86-142","article-title":"Histochemical and biochemical urease localization in the periplasm and outer membrane of two Proteus mirabilis strains","volume":"32","author":"McLean","year":"1986","journal-title":"Can. J. Microbiol."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Armbruster, C.E., Mobley, H.L.T., and Pearson, M.M. (2018). Pathogenesis of Proteus mirabilis Infection. EcoSal Plus, 8.","DOI":"10.1128\/ecosalplus.esp-0009-2017"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1128\/IAI.00718-10","article-title":"Adhesion, invasion, and agglutination mediated by two trimeric autotransporters in the human uropathogen Proteus mirabilis","volume":"78","author":"Alamuri","year":"2010","journal-title":"Infect. Immun."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1128\/IAI.01050-08","article-title":"Vaccination with proteus toxic agglutinin, a hemolysin-independent cytotoxin in vivo, protects against Proteus mirabilis urinary tract infection","volume":"77","author":"Alamuri","year":"2009","journal-title":"Infect. Immun."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S1286-4579(00)01304-6","article-title":"Pathogenesis of Proteus mirabilis urinary tract infection","volume":"2","author":"Coker","year":"2000","journal-title":"Microbes Infect."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1128\/jb.172.3.1206-1216.1990","article-title":"Nucleotide sequencing of the Proteus mirabilis calcium-independent hemolysin genes (hpmA and hpmB) reveals sequence similarity with the Serratia marcescens hemolysin genes (shlA and shlB)","volume":"172","author":"Uphoff","year":"1990","journal-title":"J. Bacteriol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1073\/pnas.1601720113","article-title":"Proteus mirabilis fimbriae- and urease-dependent clusters assemble in an extracellular niche to initiate bladder stone formation","volume":"113","author":"Schaffer","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1128\/iai.60.11.4740-4746.1992","article-title":"Ability of Proteus mirabilis to invade human urothelial cells is coupled to motility and swarming differentiation","volume":"60","author":"Allison","year":"1992","journal-title":"Infect. Immun."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1099\/00222615-48-7-623","article-title":"Investigation of the types and characteristics of the proteolytic enzymes formed by diverse strains of Proteus species","volume":"48","author":"Senior","year":"1999","journal-title":"J. Med. Microbiol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1046\/j.1365-2958.1999.01401.x","article-title":"ZapA, the IgA-degrading metalloprotease of Proteus mirabilis, is a virulence factor expressed specifically in swarmer cells","volume":"32","author":"Walker","year":"1999","journal-title":"Mol. Microbiol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1128\/IAI.00122-08","article-title":"ZapA, a virulence factor in a rat model of Proteus mirabilis-induced acute and chronic prostatitis","volume":"76","author":"Phan","year":"2008","journal-title":"Infect. Immun."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1099\/jmm.0.47314-0","article-title":"The type III secretion system of Proteus mirabilis HI4320 does not contribute to virulence in the mouse model of ascending urinary tract infection","volume":"56","author":"Pearson","year":"2007","journal-title":"J. Med. Microbiol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1128\/JB.01981-07","article-title":"Complete genome sequence of uropathogenic Proteus mirabilis, a master of both adherence and motility","volume":"190","author":"Pearson","year":"2008","journal-title":"J. Bacteriol."},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Armbruster, C.E., Forsyth-DeOrnellas, V., Johnson, A.O., Smith, S.N., Zhao, L., Wu, W., and Mobley, H.L.T. (2017). Genome-wide transposon mutagenesis of Proteus mirabilis: Essential genes, fitness factors for catheter-associated urinary tract infection, and the impact of polymicrobial infection on fitness requirements. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006434"},{"key":"ref_170","first-page":"395","article-title":"Oral vaccination against Porteus mirabilis","volume":"57","author":"Jones","year":"1976","journal-title":"Br. J. Exp. Pathol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pep.2014.10.001","article-title":"Protective immunity induced by the vaccination of recombinant Proteus mirabilis OmpA expressed in Pichia pastoris","volume":"105","author":"Zhang","year":"2015","journal-title":"Protein Expr. Purif."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijbiomac.2013.02.006","article-title":"Effects of Taishan Pinus massoniana pollen polysaccharide on the subunit vaccine of Proteus mirabilis in birds","volume":"56","author":"Cui","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Derbise, A., Hanada, Y., Khalife, M., Carniel, E., and Demeure, C.E. (2015). Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination. PLoS Negl. Trop. Dis., 9.","DOI":"10.1371\/journal.pntd.0004162"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.molimm.2014.12.008","article-title":"Intranasal immunization with fusion protein MrpH\u00b7FimH and MPL adjuvant confers protection against urinary tract infections caused by uropathogenic Escherichia coli and Proteus mirabilis","volume":"64","author":"Habibi","year":"2015","journal-title":"Mol. Immunol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.micpath.2018.02.023","article-title":"Construction and evaluation of the immune protection of a recombinant divalent protein composed of the MrpA from MR\/P fimbriae and flagellin of Proteus mirabilis strain against urinary tract infection","volume":"117","author":"Habibi","year":"2018","journal-title":"Microb. Pathog."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.intimp.2015.05.027","article-title":"Evaluation of the effect of MPL and delivery route on immunogenicity and protectivity of different formulations of FimH and MrpH from uropathogenic Escherichia coli and Proteus mirabilis in a UTI mouse model","volume":"28","author":"Habibi","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/IAI.72.1.66-75.2004","article-title":"Development of an intranasal vaccine to prevent urinary tract infection by Proteus mirabilis","volume":"72","author":"Li","year":"2004","journal-title":"Infect. Immun."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"7306","DOI":"10.1128\/IAI.72.12.7306-7310.2004","article-title":"Use of translational fusion of the MrpH fimbrial adhesin-binding domain with the cholera toxin A2 domain, coexpressed with the cholera toxin B subunit, as an intranasal vaccine to prevent experimental urinary tract infection by Proteus mirabilis","volume":"72","author":"Li","year":"2004","journal-title":"Infect. Immun."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.micpath.2017.11.015","article-title":"Determination immunogenic property of truncated MrpH.FliC as a vaccine candidate against urinary tract infections caused by Proteus mirabilis","volume":"114","author":"Bameri","year":"2018","journal-title":"Microb. Pathog."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s10482-014-0175-7","article-title":"Native flagellin does not protect mice against an experimental Proteus mirabilis ascending urinary tract infection and neutralizes the protective effect of MrpA fimbrial protein","volume":"105","author":"Scavone","year":"2014","journal-title":"Antonie Leeuwenhoek"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1099\/jmm.0.030460-0","article-title":"Nasal immunization with attenuated Salmonella typhimurium expressing an MrpA-TetC fusion protein significantly reduces Proteus mirabilis colonization in the mouse urinary tract","volume":"60","author":"Scavone","year":"2011","journal-title":"J. Med. Microbiol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.molimm.2018.03.001","article-title":"A novel multi-peptide subunit vaccine admixed with AddaVax adjuvant produces significant immunogenicity and protection against Proteus mirabilis urinary tract infection in mice model","volume":"96","author":"Choubini","year":"2018","journal-title":"Mol. Immunol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1177\/1087057116629923","article-title":"Identification of Inhibitors of Pseudomonas aeruginosa Exotoxin-S ADP-Ribosyltransferase Activity","volume":"21","author":"Pinto","year":"2016","journal-title":"J. Biomol. Screen."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1128\/AAC.02242-15","article-title":"Inhibition of Pseudomonas aeruginosa ExsA DNA-Binding Activity by N-Hydroxybenzimidazoles","volume":"60","author":"Marsden","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"e01202-17","DOI":"10.1128\/AAC.01202-17","article-title":"Impact of Type III Secretion Effectors and of Phenoxyacetamide Inhibitors of Type III Secretion on Abscess Formation in a Mouse Model of Pseudomonas aeruginosa Infection","volume":"61","author":"Berube","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"e00060-17","DOI":"10.1128\/AAC.00060-17","article-title":"Synthetic Cyclic Peptomers as Type III Secretion System Inhibitors","volume":"61","author":"Lam","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1039\/C9MD00146H","article-title":"On the road to structure-based development of anti-virulence therapeutics targeting the type III secretion system injectisome","volume":"10","author":"Lyons","year":"2019","journal-title":"Medchemcomm"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1002\/1873-3468.12291","article-title":"Structural analysis of Pseudomonas aeruginosa H3-T6SS immunity proteins","volume":"590","author":"Yang","year":"2016","journal-title":"FEBS Lett."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/ja.2017.64","article-title":"The salicylidene acylhydrazide INP0341 attenuates Pseudomonas aeruginosa virulence in vitro and in vivo","volume":"70","author":"Uusitalo","year":"2017","journal-title":"J. Antibiot."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ejmech.2017.11.036","article-title":"Structure-activity relationships for inhibitors of Pseudomonas aeruginosa exoenzyme S ADP-ribosyltransferase activity","volume":"143","author":"Saleeb","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.bbrc.2019.04.055","article-title":"Identification of a potent inhibitor of type II secretion system from Pseudomonas aeruginosa","volume":"513","author":"Swietnicki","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tim.2016.10.003","article-title":"Adaptor Proteins of Type VI Secretion System Effectors","volume":"25","author":"Unterweger","year":"2017","journal-title":"Trends Microbiol."},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"Han, Y., Wang, T., Chen, G., Pu, Q., Liu, Q., Zhang, Y., Xu, L., Wu, M., and Liang, H. (2019). A Pseudomonas aeruginosa type VI secretion system regulated by CueR facilitates copper acquisition. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1008198"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nature12074","article-title":"Diverse type VI secretion phospholipases are functionally plastic antibacterial effectors","volume":"496","author":"Russell","year":"2013","journal-title":"Nature"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev-micro-121809-151619","article-title":"Structure and regulation of the type VI secretion system","volume":"66","author":"Silverman","year":"2012","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature10244","article-title":"Type VI secretion delivers bacteriolytic effectors to target cells","volume":"475","author":"Russell","year":"2011","journal-title":"Nature"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nrmicro2199","article-title":"The type III secretion system of Pseudomonas aeruginosa: Infection by injection","volume":"7","author":"Hauser","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1098\/rstb.2000.0608","article-title":"Type III secretion: A bacterial device for close combat with cells of their eukaryotic host","volume":"355","author":"Cornelis","year":"2000","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"e01185-17","DOI":"10.1128\/mBio.01185-17","article-title":"Unraveling the Self-Assembly of the Pseudomonas aeruginosa XcpQ Secretin Periplasmic Domain Provides New Molecular Insights into Type II Secretion System Secreton Architecture and Dynamics","volume":"8","author":"Douzi","year":"2017","journal-title":"mBio"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1107\/S0907444910051954","article-title":"Structure of the minor pseudopilin XcpW from the Pseudomonas aeruginosa type II secretion system","volume":"67","author":"Franz","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1099\/mic.0.045849-0","article-title":"Role of fimV in type II secretion system-dependent protein secretion of Pseudomonas aeruginosa on solid medium","volume":"157","author":"Michel","year":"2011","journal-title":"Microbiology"},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Faucher, F., Zhang, W., Wang, S., Neville, N., Poole, K., Zheng, J., and Jia, Z. (2018). Structure-guided disruption of the pseudopilus tip complex inhibits the Type II secretion in Pseudomonas aeruginosa. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1007343"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"e00014-17","DOI":"10.1128\/IAI.00014-17","article-title":"Expanding Role of Type II Secretion in Bacterial Pathogenesis and Beyond","volume":"85","author":"Cianciotto","year":"2017","journal-title":"Infect. Immun."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/infdis\/jir045","article-title":"Type II secretion system of Pseudomonas aeruginosa: In vivo evidence of a significant role in death due to lung infection","volume":"203","author":"Jyot","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"36369","DOI":"10.1074\/jbc.274.51.36369","article-title":"The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases","volume":"274","author":"Goehring","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"12082","DOI":"10.1074\/jbc.M109039200","article-title":"Auto-ADP-ribosylation of Pseudomonas aeruginosa ExoS","volume":"277","author":"Riese","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"13899","DOI":"10.1073\/pnas.95.23.13899","article-title":"ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system","volume":"95","author":"Yahr","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"41326","DOI":"10.1074\/jbc.M302472200","article-title":"In vivo phospholipase activity of the Pseudomonas aeruginosa cytotoxin ExoU and protection of mammalian cells with phospholipase A2 inhibitors","volume":"278","author":"Phillips","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1093\/emboj\/cdg290","article-title":"The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU","volume":"22","author":"Sato","year":"2003","journal-title":"EMBO J."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1128\/IAI.72.12.6969-6977.2004","article-title":"Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung","volume":"72","author":"Shaver","year":"2004","journal-title":"Infect. Immun."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1574-6976.1998.tb00366.x","article-title":"GSP-dependent protein secretion in gram-negative bacteria: The Xcp system of Pseudomonas aeruginosa","volume":"22","author":"Filloux","year":"1998","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"e02250-16","DOI":"10.1128\/mBio.02250-16","article-title":"Pseudomonas aeruginosa Pore-Forming Exolysin and Type IV Pili Cooperate To Induce Host Cell Lysis","volume":"8","author":"Basso","year":"2017","journal-title":"mBio"},{"key":"ref_213","doi-asserted-by":"crossref","unstructured":"Turner, K.H., Everett, J., Trivedi, U., Rumbaugh, K.P., and Whiteley, M. (2014). Requirements for Pseudomonas aeruginosa acute burn and chronic surgical wound infection. PLoS Genet., 10.","DOI":"10.1371\/journal.pgen.1004518"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1476-0711-5-14","article-title":"Identification of multi-drug resistant Pseudomonas aeruginosa clinical isolates that are highly disruptive to the intestinal epithelial barrier","volume":"5","author":"Zaborina","year":"2006","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3390\/biology2041242","article-title":"The role of the bacterial flagellum in adhesion and virulence","volume":"2","author":"Haiko","year":"2013","journal-title":"Biology"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev.mi.29.100175.000455","article-title":"Ecology, physiology, and genetics of fimbriae and pili","volume":"29","author":"Ottow","year":"1975","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1146\/annurev-micro-092611-150055","article-title":"Pseudomonas aeruginosa twitching motility: Type IV pili in action","volume":"66","author":"Burrows","year":"2012","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.tim.2004.09.002","article-title":"Bacterial flagellins: Mediators of pathogenicity and host immune responses in mucosa","volume":"12","author":"Ramos","year":"2004","journal-title":"Trends Microbiol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1128\/iai.49.3.770-774.1985","article-title":"Electrophoretic separation and molecular weight characterization of Pseudomonas aeruginosa H-antigen flagellins","volume":"49","author":"Allison","year":"1985","journal-title":"Infect. Immun."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"5689709","DOI":"10.1155\/2017\/5689709","article-title":"Immunization with Bivalent Flagellin Protects Mice against Fatal Pseudomonas aeruginosa Pneumonia","volume":"2017","author":"Behrouz","year":"2017","journal-title":"J. Immunol. Res."},{"key":"ref_221","doi-asserted-by":"crossref","unstructured":"Hegerle, N., Choi, M., Sinclair, J., Amin, M.N., Ollivault-Shiflett, M., Curtis, B., Laufer, R.S., Shridhar, S., Brammer, J., and Toapanta, F.R. (2018). Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0203143"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"103697","DOI":"10.1016\/j.micpath.2019.103697","article-title":"A trivalent vaccine consisting of \u201cflagellin A + B and pilin\u201d protects against Pseudomonas aeruginosa infection in a murine burn model","volume":"138","author":"Hashemi","year":"2020","journal-title":"Microb. Pathog."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.imlet.2016.04.002","article-title":"Flagellin and pilin immunization against multi-drug resistant Pseudomonas aeruginosa protects mice in the burn wound sepsis model","volume":"176","author":"Korpi","year":"2016","journal-title":"Immunol. Lett."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/femsre\/fux020","article-title":"Structure, function and regulation of Pseudomonas aeruginosa porins","volume":"41","author":"Chevalier","year":"2017","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.3389\/fmicb.2018.01062","article-title":"PA0833 Is an OmpA C-Like Protein That Confers Protection Against Pseudomonas aeruginosa Infection","volume":"9","author":"Yang","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1016\/j.vaccine.2016.07.017","article-title":"A DNA vaccine encoding VP22 of herpes simplex virus type I (HSV-1) and OprF confers enhanced protection from Pseudomonas aeruginosa in mice","volume":"34","author":"Yu","year":"2016","journal-title":"Vaccine"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.3892\/or.2016.4694","article-title":"Herpes simplex virus type 1 VP22-mediated intercellular delivery of PTEN increases the antitumor activity of PTEN in esophageal squamous cell carcinoma cells in vitro and in vivo","volume":"35","author":"Yu","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13054-020-2792-z","article-title":"Efficacy, immunogenicity, and safety of IC43 recombinant Pseudomonas aeruginosa vaccine in mechanically ventilated intensive care patients-a randomized clinical trial","volume":"24","author":"Adlbrecht","year":"2020","journal-title":"Crit. Care"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jmii.2016.08.014","article-title":"Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa","volume":"51","author":"Hassan","year":"2018","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/1348-0421.12291","article-title":"Salmonella Typhimurium strain expressing OprF-OprI protects mice against fatal infection by Pseudomonas aeruginosa","volume":"59","author":"Zhang","year":"2015","journal-title":"Microbiol. Immunol."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ijbiomac.2020.05.057","article-title":"Oligomerization of IC43 resulted in improved immunogenicity and protective efficacy against Pseudomonas aeruginosa lung infection","volume":"159","author":"Jing","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.2147\/IDR.S244081","article-title":"Protective Efficacy of the OprF\/OprI\/PcrV Recombinant Chimeric Protein Against Pseudomonas aeruginosa in the Burned BALB\/c Mouse Model","volume":"13","author":"Fakoor","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1164\/rccm.201202-0182OC","article-title":"Th17-stimulating protein vaccines confer protection against Pseudomonas aeruginosa pneumonia","volume":"186","author":"Wu","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.clim.2017.09.022","article-title":"Vaccination with a recombinant OprL fragment induces a Th17 response and confers serotype-independent protection against Pseudomonas aeruginosa infection in mice","volume":"183","author":"Gao","year":"2017","journal-title":"Clin. Immunol."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.3389\/fimmu.2018.01737","article-title":"Construction of a Protective Vaccine against Lipopolysaccharide-Heterologous Pseudomonas aeruginosa Strains Based on Expression Profiling of Outer Membrane Proteins during Infection","volume":"9","author":"Liu","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/7391","article-title":"Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury","volume":"5","author":"Sawa","year":"1999","journal-title":"Nat. Med."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"5908","DOI":"10.1128\/IAI.69.9.5908-5910.2001","article-title":"PcrV immunization enhances survival of burned Pseudomonas aeruginosa-infected mice","volume":"69","author":"Holder","year":"2001","journal-title":"Infect. Immun."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3389\/fimmu.2019.00781","article-title":"Rational Design of a Chimeric Derivative of PcrV as a Subunit Vaccine against Pseudomonas aeruginosa","volume":"10","author":"Wan","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/1348-0421.12467","article-title":"Efficacy comparison of adjuvants in PcrV vaccine against Pseudomonas aeruginosa pneumonia","volume":"61","author":"Hamaoka","year":"2017","journal-title":"Microbiol. Immunol."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"e00116-19","DOI":"10.1128\/mSphere.00116-19","article-title":"A Live Salmonella Vaccine Delivering PcrV through the Type III Secretion System Protects against Pseudomonas aeruginosa","volume":"4","author":"McConnell","year":"2019","journal-title":"mSphere"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/1348-0421.12658","article-title":"The protective effects of nasal PcrV-CpG oligonucleotide vaccination against Pseudomonas aeruginosa pneumonia","volume":"62","author":"Naito","year":"2018","journal-title":"Microbiol. Immunol."},{"key":"ref_242","first-page":"15","article-title":"Immunization with 3-oxododecanoyl-L-homoserine lactone-r-PcrV conjugate enhances survival of mice against lethal burn infections caused by Pseudomonas aeruginosa","volume":"15","author":"Golpasha","year":"2015","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"6926","DOI":"10.1016\/j.vaccine.2018.10.010","article-title":"PLGA-encapsulation of the Pseudomonas aeruginosa PopB vaccine antigen improves Th17 responses and confers protection against experimental acute pneumonia","volume":"36","author":"Schaefers","year":"2018","journal-title":"Vaccine"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"583008","DOI":"10.3389\/fimmu.2020.583008","article-title":"Development of a Broadly Protective, Self-Adjuvanting Subunit Vaccine to Prevent Infections by Pseudomonas aeruginosa","volume":"11","author":"Das","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1248\/bpb.b19-01052","article-title":"Construction of Genomic Library and High-Throughput Screening of Pseudomonas aeruginosa Novel Antigens for Potential Vaccines","volume":"43","author":"Xu","year":"2020","journal-title":"Biol. Pharm. Bull."},{"key":"ref_246","first-page":"367","article-title":"Protective effect of pilin protein with alum + naloxone adjuvant against acute pulmonary Pseudomonas aeruginosa infection","volume":"44","author":"Banadkoki","year":"2016","journal-title":"Biol. J. Int. Assoc. Biol. Stand."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ijmm.2016.06.005","article-title":"Heterologous Pseudomonas aeruginosa O-antigen delivery using a Salmonella enterica serovar Typhimurium wecA mutant strain","volume":"306","author":"Bridge","year":"2016","journal-title":"Int. J. Med. Microbiol. IJMM"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev.micro.091208.073413","article-title":"Biological functions and biogenesis of secreted bacterial outer membrane vesicles","volume":"64","author":"Kulp","year":"2010","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1016\/j.vaccine.2011.06.001","article-title":"Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii","volume":"29","author":"McConnell","year":"2011","journal-title":"Vaccine"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.vaccine.2018.01.034","article-title":"Immunization with Pseudomonas aeruginosa outer membrane vesicles stimulates protective immunity in mice","volume":"36","author":"Zhang","year":"2018","journal-title":"Vaccine"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"15480","DOI":"10.1038\/ncomms15480","article-title":"Design of live attenuated bacterial vaccines based on D-glutamate auxotrophy","volume":"8","author":"Cabral","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_252","doi-asserted-by":"crossref","unstructured":"Cabral, M.P., Correia, A., Vilanova, M., Gartner, F., Moscoso, M., Garcia, P., Vallejo, J.A., Perez, A., Francisco-Tome, M., and Fuentes-Valverde, V. (2020). A live auxotrophic vaccine confers mucosal immunity and protection against lethal pneumonia caused by Pseudomonas aeruginosa. PLoS Pathog., 16.","DOI":"10.1371\/journal.ppat.1008311"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.4315\/0362-028X.JFP-16-204","article-title":"Foodborne Disease Outbreaks Associated with Organic Foods in the United States","volume":"79","author":"Harvey","year":"2016","journal-title":"J. Food Prot."},{"key":"ref_254","doi-asserted-by":"crossref","unstructured":"Augustin, J.-C., Kooh, P., Bayeux, T., Guillier, L., Meyer, T., Jourdan-Da Silva, N., Villena, I., Sanaa, M., Cerf, O., and On Behalf of the Anses Working Group on Consumer Information on Foodborne Biological Risks (2020). Contribution of Foods and Poor Food-Handling Practices to the Burden of Foodborne Infectious Diseases in France. Foods, 9.","DOI":"10.3390\/foods9111644"},{"key":"ref_255","doi-asserted-by":"crossref","unstructured":"World Health Organization (2019). Typhoid vaccines: WHO position paper, March 2018\u2014Recommendations. Vaccine, 37, 214\u2013216.","DOI":"10.1016\/j.vaccine.2018.04.022"},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1073\/pnas.0400932101","article-title":"Salmonella typhi encodes a functional cytolethal distending toxin that is delivered into host cells by a bacterial-internalization pathway","volume":"101","author":"Haghjoo","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S1286-4579(01)01488-5","article-title":"The Salmonella pathogenicity island-1 type III secretion system","volume":"3","author":"Lostroh","year":"2001","journal-title":"Microbes Infect."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1128\/IAI.00931-09","article-title":"Systematic analysis of the SsrAB virulon of Salmonella enterica","volume":"78","author":"Xu","year":"2010","journal-title":"Infect. Immun."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1128\/CMR.12.3.405","article-title":"Molecular basis of the interaction of Salmonella with the intestinal mucosa","volume":"12","author":"Darwin","year":"1999","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S1286-4579(01)01491-5","article-title":"Salmonella intracellular proliferation: Where, when and how?","volume":"3","year":"2001","journal-title":"Microbes Infect."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0966-842X(97)01099-8","article-title":"How Salmonella became a pathogen","volume":"5","author":"Groisman","year":"1997","journal-title":"Trends Microbiol."},{"key":"ref_262","doi-asserted-by":"crossref","unstructured":"Pezoa, D., Yang, H.-J., Blondel, C.J., Santiviago, C.A., Andrews-Polymenis, H.L., and Contreras, I. (2013). The type VI secretion system encoded in SPI-6 plays a role in gastrointestinal colonization and systemic spread of Salmonella enterica serovar Typhimurium in the chicken. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0063917"},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00284-011-9935-z","article-title":"Molecular characterization of a functional type VI secretion system in Salmonella enterica serovar Typhi","volume":"63","author":"Wang","year":"2011","journal-title":"Curr. Microbiol."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"18404","DOI":"10.1038\/s41598-019-54690-1","article-title":"Prophylactic potential of cytolethal distending toxin B (CdtB) subunit of typhoid toxin against Typhoid fever","volume":"9","author":"Thakur","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_265","doi-asserted-by":"crossref","unstructured":"Hu, M., Zhao, W., Li, H., Gu, J., Yan, Q., Zhou, X., Pan, Z., Cui, G., and Jiao, X. (2018). Immunization with recombinant Salmonella expressing SspH2-EscI protects mice against wild type Salmonella infection. BMC Vet. Res., 14.","DOI":"10.1186\/s12917-018-1404-5"},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"e00473-17","DOI":"10.1128\/IAI.00473-17","article-title":"Characterization and Protective Efficacy of Type III Secretion Proteins as a Broadly Protective Subunit Vaccine against Salmonella enterica Serotypes","volume":"86","author":"Kumar","year":"2018","journal-title":"Infect. Immun."},{"key":"ref_267","doi-asserted-by":"crossref","unstructured":"Jneid, B., Moreau, K., Plaisance, M., Rouaix, A., Dano, J., and Simon, S. (2016). Role of T3SS-1 SipD Protein in Protecting Mice against Non-typhoidal Salmonella Typhimurium. PLoS Negl. Trop. Dis., 10.","DOI":"10.1371\/journal.pntd.0005207"},{"key":"ref_268","doi-asserted-by":"crossref","unstructured":"Jneid, B., Rouaix, A., Feraudet-Tarisse, C., and Simon, S. (2020). SipD and IpaD induce a cross-protection against Shigella and Salmonella infections. PLoS Negl. Trop. Dis., 14.","DOI":"10.1371\/journal.pntd.0008326"},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.4049\/jimmunol.1601357","article-title":"Dual Immunization with SseB\/Flagellin Provides Enhanced Protection against Salmonella Infection Mediated by Circulating Memory Cells","volume":"199","author":"Lee","year":"2017","journal-title":"J. Immunol."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/cmi.12379","article-title":"An AIL family protein promotes type three secretion system-1-independent invasion and pathogenesis of Salmonella enterica serovar Typhi","volume":"17","author":"Chowdhury","year":"2015","journal-title":"Cell. Microbiol."},{"key":"ref_271","first-page":"e12982","article-title":"Epithelial invasion by Salmonella Typhi using STIV-Met interaction","volume":"21","author":"Chowdhury","year":"2019","journal-title":"Cell. Microbiol."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.imbio.2019.02.011","article-title":"Salmonella Typhi outer membrane protein STIV is a potential candidate for vaccine development against typhoid and paratyphoid fever","volume":"224","author":"Das","year":"2019","journal-title":"Immunobiology"},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"7094","DOI":"10.1016\/j.vaccine.2020.08.074","article-title":"rOmpF and OMVs as efficient subunit vaccines against Salmonella enterica serovar Enteritidis infections in poultry farms","volume":"38","author":"Li","year":"2020","journal-title":"Vaccine"},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2147\/IJN.S238445","article-title":"Oral Deliverable Mucoadhesive Chitosan-Salmonella Subunit Nanovaccine for Layer Chickens","volume":"15","author":"Renu","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"ref_275","doi-asserted-by":"crossref","unstructured":"Baliban, S.M., Yang, M., Ramachandran, G., Curtis, B., Shridhar, S., Laufer, R.S., Wang, J.Y., Van Druff, J., Higginson, E.E., and Hegerle, N. (2017). Development of a glycoconjugate vaccine to prevent invasive Salmonella  Typhimurium infections in sub-Saharan Africa. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005493"},{"key":"ref_276","doi-asserted-by":"crossref","unstructured":"Baliban, S.M., Curtis, B., Toema, D., Tennant, S.M., Levine, M.M., Pasetti, M.F., and Simon, R. (2018). Immunogenicity and efficacy following sequential parenterally-administered doses of Salmonella Enteritidis COPS:FliC glycoconjugates in infant and adult mice. PLoS Negl. Trop. Dis., 12.","DOI":"10.1371\/journal.pntd.0006522"},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"e01220-16","DOI":"10.1128\/mBio.01220-16","article-title":"aroA-Deficient Salmonella enterica Serovar Typhimurium Is More Than a Metabolically Attenuated Mutant","volume":"7","author":"Felgner","year":"2016","journal-title":"mBio"},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2307\/1591205","article-title":"Humoral responses and salmonellosis protection in chickens given a vitamin-dependent Salmonella typhimurium mutant","volume":"35","author":"Alderton","year":"1991","journal-title":"Avian Dis."},{"key":"ref_279","first-page":"99","article-title":"Live vaccine against swine paratyphoid from the attenuated smooth strain C500 of Salmonella choleraesuis","volume":"2","author":"Fang","year":"1981","journal-title":"Chin. J. Anim. Vet. Sci"},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"7715","DOI":"10.1016\/j.vaccine.2018.10.079","article-title":"Rewiring of one carbon metabolism in Salmonella serves as an excellent live vaccine against systemic salmonellosis","volume":"36","author":"Datey","year":"2018","journal-title":"Vaccine"},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.rvsc.2016.06.011","article-title":"Evaluation of protective immune response against fowl typhoid in chickens vaccinated with the attenuated strain Salmonella gallinarum DeltacobSDeltacbiA","volume":"107","author":"Diaz","year":"2016","journal-title":"Res. Vet. Sci."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12275-019-8416-0","article-title":"Effective mucosal live attenuated Salmonella vaccine by deleting phosphotransferase system component genes ptsI and crr","volume":"57","author":"Zhi","year":"2019","journal-title":"J. Microbiol."},{"key":"ref_283","doi-asserted-by":"crossref","unstructured":"Chaudhuri, R.R., Morgan, E., Peters, S.E., Pleasance, S.J., Hudson, D.L., Davies, H.M., Wang, J., van Diemen, P.M., Buckley, A.M., and Bowen, A.J. (2013). Comprehensive assignment of roles for Salmonella typhimurium genes in intestinal colonization of food-producing animals. PLoS Genet., 9.","DOI":"10.1371\/journal.pgen.1003456"},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"151337","DOI":"10.1016\/j.ijmm.2019.151337","article-title":"Immunogenic potential and protective efficacy of a sptP deletion mutant of Salmonella Enteritidis as a live vaccine for chickens against a lethal challenge","volume":"309","author":"Guo","year":"2019","journal-title":"Int. J. Med. Microbiol. IJMM"},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3389\/fimmu.2020.01277","article-title":"Salmonella typhimurium Lacking YjeK as a Candidate Live Attenuated Vaccine against Invasive Salmonella Infection","volume":"11","author":"Park","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"103795","DOI":"10.1016\/j.micpath.2019.103795","article-title":"Characterization and protective efficacy of a Salmonella pathogenicity island 2 (SPI2) mutant of Salmonella Paratyphi A","volume":"137","author":"Yin","year":"2019","journal-title":"Microb. Pathog."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1128\/IAI.70.7.3457-3467.2002","article-title":"Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers","volume":"70","author":"Hindle","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_288","doi-asserted-by":"crossref","unstructured":"Li, Q., Zhu, Y., Ren, J., Qiao, Z., Yin, C., Xian, H., Yuan, Y., Geng, S., and Jiao, X. (2019). Evaluation of the Safety and Protection Efficacy of spiC and nmpC or rfaL Deletion Mutants of Salmonella Enteritidis as Live Vaccine Candidates for Poultry Non-Typhoidal Salmonellosis. Vaccines, 7.","DOI":"10.3390\/vaccines7040202"},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.vaccine.2020.12.002","article-title":"Immunogenicity and protection efficacy of a Salmonella enterica serovar Typhimurium fnr, arcA and fliC mutant","volume":"39","author":"Zhao","year":"2021","journal-title":"Vaccine"},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3389\/fcimb.2017.00391","article-title":"Two Novel Salmonella Bivalent Vaccines Confer Dual Protection against Two Salmonella Serovars in Mice","volume":"7","author":"Zhao","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.coi.2021.03.009","article-title":"Supply and delivery of vaccines for global health","volume":"71","author":"Excler","year":"2021","journal-title":"Curr. Opin. Immunol."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/j.vaccine.2016.02.075","article-title":"Status of vaccine research and development for Shigella","volume":"34","author":"Mani","year":"2016","journal-title":"Vaccine"},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1016\/j.vaccine.2015.06.102","article-title":"Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella dysenteriae type 1 administered to healthy adults: A single blind, partially randomized Phase I study","volume":"33","author":"Hatz","year":"2015","journal-title":"Vaccine"},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"6906","DOI":"10.1021\/acs.biochem.8b01077","article-title":"Shutting Down Shigella Secretion: Characterizing Small Molecule Type Three Secretion System ATPase Inhibitors","volume":"57","author":"Case","year":"2018","journal-title":"Biochemistry"},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/cmdc.201700348","article-title":"Characterization of Small-Molecule Scaffolds That Bind to the Shigella Type III Secretion System Protein IpaD","volume":"12","author":"Dey","year":"2017","journal-title":"ChemMedChem"},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1128\/IAI.00919-13","article-title":"Small-molecule inhibitor of the Shigella flexneri master virulence regulator VirF","volume":"81","author":"Koppolu","year":"2013","journal-title":"Infect. Immun."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1128\/JB.01004-08","article-title":"Small-molecule type III secretion system inhibitors block assembly of the Shigella type III secreton","volume":"191","author":"Veenendaal","year":"2009","journal-title":"J. Bacteriol."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.micres.2015.08.006","article-title":"The roles of the virulence factor IpaB in Shigella spp. in the escape from immune cells and invasion of epithelial cells","volume":"181","author":"Yang","year":"2015","journal-title":"Microbiol. Res."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1021\/bi400160a","article-title":"Structure and biophysics of type III secretion in bacteria","volume":"52","author":"Chatterjee","year":"2013","journal-title":"Biochemistry"},{"key":"ref_300","doi-asserted-by":"crossref","unstructured":"Hotinger, J.A., and May, A.E. (2019). Animal Models of Type III Secretion System-Mediated Pathogenesis. Pathogens, 8.","DOI":"10.3390\/pathogens8040257"},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1128\/MMBR.62.2.379-433.1998","article-title":"Type III protein secretion systems in bacterial pathogens of animals and plants","volume":"62","author":"Hueck","year":"1998","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1002\/jps.24659","article-title":"Biophysical Characterization of the Type III Secretion System Translocator Proteins and the Translocator Proteins Attached to Bacterium-Like Particles","volume":"104","author":"Chen","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/icb.2015.24","article-title":"Shigella IpaB and IpaD displayed on L. lactis bacterium-like particles induce protective immunity in adult and infant mice","volume":"93","author":"Heine","year":"2015","journal-title":"Immunol. Cell Biol."},{"key":"ref_304","first-page":"299","article-title":"Studies on the contribution of the F1 capsule-associated plasmid pFra to the virulence of Yersinia pestis","volume":"13","author":"Welkos","year":"1995","journal-title":"Contrib. Microbiol. Immunol."},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/CMR.10.1.35","article-title":"Yersinia pestis\u2014Etiologic agent of plague","volume":"10","author":"Perry","year":"1997","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1001\/jama.283.17.2281","article-title":"Plague as a biological weapon: Medical and public health management. Working Group on Civilian Biodefense","volume":"283","author":"Inglesby","year":"2000","journal-title":"JAMA"},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"D56","DOI":"10.1016\/j.vaccine.2009.07.068","article-title":"Plague","volume":"27","author":"Williamson","year":"2009","journal-title":"Vaccine"},{"key":"ref_308","doi-asserted-by":"crossref","unstructured":"Sebbane, F., and Lema\u00eetre, N. (2021). Antibiotic Therapy of Plague: A Review. Biomolecules, 11.","DOI":"10.3390\/biom11050724"},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s12026-013-8454-3","article-title":"The Yersinia pestis type III secretion system: Expression, assembly and role in the evasion of host defenses","volume":"57","author":"Plano","year":"2013","journal-title":"Immunol. Res."},{"key":"ref_310","doi-asserted-by":"crossref","unstructured":"Swietnicki, W., Carmany, D., Retford, M., Guelta, M., Dorsey, R., Bozue, J., Lee, M.S., and Olson, M.A. (2011). Identification of small-molecule inhibitors of Yersinia pestis Type III secretion system YscN ATPase. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0019716"},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1128\/IAI.71.10.5892-5899.2003","article-title":"The ability to replicate in macrophages is conserved between Yersinia pestis and Yersinia pseudotuberculosis","volume":"71","author":"Pujol","year":"2003","journal-title":"Infect. Immun."},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1128\/IAI.00062-10","article-title":"Global gene expression profiling of Yersinia pestis replicating inside macrophages reveals the roles of a putative stress-induced operon in regulating type III secretion and intracellular cell division","volume":"78","author":"Fukuto","year":"2010","journal-title":"Infect. Immun."},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/mpat.2002.0498","article-title":"Anti-V antigen antibody protects macrophages from Yersinia pestis-induced cell death and promotes phagocytosis","volume":"32","author":"Weeks","year":"2002","journal-title":"Microb. Pathog."},{"key":"ref_314","doi-asserted-by":"crossref","unstructured":"Hinnebusch, B.J., Jarrett, C.O., and Bland, D.M. (2021). Molecular and Genetic Mechanisms That Mediate Transmission of Yersinia pestis by Fleas. Biomolecules, 11.","DOI":"10.3390\/biom11020210"},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/infdis\/155.1.113","article-title":"Septicemic plague in New Mexico","volume":"155","author":"Hull","year":"1987","journal-title":"J. Infect. Dis."},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1073\/pnas.0509544103","article-title":"Role of the Yersinia pestis plasminogen activator in the incidence of distinct septicemic and bubonic forms of flea-borne plague","volume":"103","author":"Sebbane","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1128\/CVI.00013-14","article-title":"Direct neutralization of type III effector translocation by the variable region of a monoclonal antibody to Yersinia pestis LcrV","volume":"21","author":"Ivanov","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3389\/fcimb.2017.00358","article-title":"Characterization of Yersinia pestis Interactions with Human Neutrophils In vitro","volume":"7","author":"Dudte","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_319","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1128\/CVI.05559-11","article-title":"Humoral and cellular immune responses to Yersinia pestis infection in long-term recovered plague patients","volume":"19","author":"Li","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1128\/IAI.73.6.3734-3739.2005","article-title":"Protein microarray for profiling antibody responses to Yersinia pestis live vaccine","volume":"73","author":"Li","year":"2005","journal-title":"Infect. Immun."},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1128\/IAI.67.4.1922-1928.1999","article-title":"Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in mice","volume":"67","author":"Benner","year":"1999","journal-title":"Infect. Immun."},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1016\/j.vaccine.2018.06.039","article-title":"Dual route vaccination for plague with emergency use applications","volume":"36","author":"Moore","year":"2018","journal-title":"Vaccine"},{"key":"ref_323","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0264-410X(98)80110-2","article-title":"Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine","volume":"16","author":"Heath","year":"1998","journal-title":"Vaccine"},{"key":"ref_324","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1128\/iai.62.10.4192-4201.1994","article-title":"Passive immunity to Yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide","volume":"62","author":"Motin","year":"1994","journal-title":"Infect. Immun."},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1128\/iai.65.2.446-451.1997","article-title":"Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen","volume":"65","author":"Roggenkamp","year":"1997","journal-title":"Infect. Immun."},{"key":"ref_326","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.3389\/fimmu.2019.01830","article-title":"Polymorphism in the Yersinia LcrV Antigen Enables Immune Escape From the Protection Conferred by an LcrV-Secreting Lactococcus lactis in a Pseudotuberculosis Mouse Model","volume":"10","author":"Daniel","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_327","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41541-019-0105-9","article-title":"Plague vaccine: Recent progress and prospects","volume":"4","author":"Sun","year":"2019","journal-title":"NPJ Vaccines"},{"key":"ref_328","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.pep.2005.02.016","article-title":"Yersinia pestis Yop secretion protein F: Purification, characterization, and protective efficacy against bubonic plague","volume":"42","author":"Swietnicki","year":"2005","journal-title":"Protein Expr. Purif."},{"key":"ref_329","doi-asserted-by":"crossref","unstructured":"Matson, J.S., Durick, K.A., Bradley, D.S., and Nilles, M.L. (2005). Immunization of mice with YscF provides protection from Yersinia pestis infections. BMC Microbiol., 5.","DOI":"10.1186\/1471-2180-5-38"},{"key":"ref_330","doi-asserted-by":"crossref","first-page":"897","DOI":"10.4049\/jimmunol.1100174","article-title":"Yersinia pestis YopE contains a dominant CD8 T cell epitope that confers protection in a mouse model of pneumonic plague","volume":"187","author":"Lin","year":"2011","journal-title":"J. Immunol."},{"key":"ref_331","doi-asserted-by":"crossref","first-page":"e00296-19","DOI":"10.1128\/IAI.00296-19","article-title":"A Recombinant Attenuated Yersinia pseudotuberculosis Vaccine Delivering a Y. pestis YopENt138-LcrV Fusion Elicits Broad Protection against Plague and Yersiniosis in Mice","volume":"87","author":"Singh","year":"2019","journal-title":"Infect. Immun."},{"key":"ref_332","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1128\/IAI.02443-14","article-title":"A bivalent typhoid live vector vaccine expressing both chromosome- and plasmid-encoded Yersinia pestis antigens fully protects against murine lethal pulmonary plague infection","volume":"83","author":"Galen","year":"2015","journal-title":"Infect. Immun."},{"key":"ref_333","doi-asserted-by":"crossref","unstructured":"Bozue, J., Cote, C.K., Chance, T., Kugelman, J., Kern, S.J., Kijek, T.K., Jenkins, A., Mou, S., Moody, K., and Fritz, D. (2014). A Yersinia pestis tat mutant is attenuated in bubonic and small-aerosol pneumonic challenge models of infection but not as attenuated by intranasal challenge. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0104524"},{"key":"ref_334","doi-asserted-by":"crossref","unstructured":"Cote, C.K., Biryukov, S.S., Klimko, C.P., Shoe, J.L., Hunter, M., Rosario-Acevedo, R., Fetterer, D.P., Moody, K.L., Meyer, J.R., and Rill, N.O. (2021). Protection Elicited by Attenuated Live Yersinia pestis Vaccine Strains against Lethal Infection with Virulent Y. pestis. Vaccines, 9.","DOI":"10.3390\/vaccines9020161"},{"key":"ref_335","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1128\/CVI.00597-12","article-title":"Evaluation of protective potential of Yersinia pestis outer membrane protein antigens as possible candidates for a new-generation recombinant plague vaccine","volume":"20","author":"Erova","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_336","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1128\/JCM.00064-11","article-title":"Characterization of an F1 deletion mutant of Yersinia pestis CO92, pathogenic role of F1 antigen in bubonic and pneumonic plague, and evaluation of sensitivity and specificity of F1 antigen capture-based dipsticks","volume":"49","author":"Sha","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"ref_337","doi-asserted-by":"crossref","first-page":"77","DOI":"10.15585\/mmwr.mm6903a5","article-title":"Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2019","volume":"69","author":"Havers","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_338","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pep.2006.12.018","article-title":"Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague","volume":"53","author":"Goodin","year":"2007","journal-title":"Protein Expr. Purif."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/11\/6\/892\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:16:29Z","timestamp":1760163389000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/11\/6\/892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,15]]},"references-count":338,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["biom11060892"],"URL":"https:\/\/doi.org\/10.3390\/biom11060892","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,15]]}}}